1023 related articles for article (PubMed ID: 25318831)
21. Non-corticosteroid treatment for nephrotic syndrome in children.
Hodson EM; Willis NS; Craig JC
Cochrane Database Syst Rev; 2008 Jan; (1):CD002290. PubMed ID: 18254005
[TBL] [Abstract][Full Text] [Related]
22. Interventions for preventing and treating kidney disease in IgA vasculitis.
Hahn D; Hodson EM; Craig JC
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD005128. PubMed ID: 36853224
[TBL] [Abstract][Full Text] [Related]
23. Interventions for minimal change disease in adults with nephrotic syndrome.
Palmer SC; Nand K; Strippoli GF
Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD001537. PubMed ID: 18253993
[TBL] [Abstract][Full Text] [Related]
24. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Habashy D; Hodson E; Craig J
Cochrane Database Syst Rev; 2004; (2):CD003594. PubMed ID: 15106208
[TBL] [Abstract][Full Text] [Related]
25. Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP).
Hahn D; Hodson EM; Willis NS; Craig JC
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD005128. PubMed ID: 26258874
[TBL] [Abstract][Full Text] [Related]
26. Interventions for renal vasculitis in adults.
Walters GD; Willis NS; Cooper TE; Craig JC
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD003232. PubMed ID: 31927782
[TBL] [Abstract][Full Text] [Related]
27. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial.
Chen M; Li H; Li XY; Lu FM; Ni ZH; Xu FF; Li XW; Chen JH; Wang HY;
Am J Med Sci; 2010 Mar; 339(3):233-8. PubMed ID: 20220333
[TBL] [Abstract][Full Text] [Related]
28. Management of Membranous Nephropathy in Western Countries.
Alfaadhel T; Cattran D
Kidney Dis (Basel); 2015 Sep; 1(2):126-37. PubMed ID: 27536673
[TBL] [Abstract][Full Text] [Related]
29. Effect of tacrolimus in idiopathic membranous nephropathy: a meta-analysis.
Santosh T; Liu H; Liu B
Chin Med J (Engl); 2014; 127(14):2693-9. PubMed ID: 25043091
[TBL] [Abstract][Full Text] [Related]
30. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
Wagner M; Earley AK; Webster AC; Schmid CH; Balk EM; Uhlig K
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007746. PubMed ID: 26633102
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review.
Perna A; Schieppati A; Zamora J; Giuliano GA; Braun N; Remuzzi G
Am J Kidney Dis; 2004 Sep; 44(3):385-401. PubMed ID: 15332211
[TBL] [Abstract][Full Text] [Related]
32. Immunosuppressive therapy for IgA nephropathy in children.
Alladin A; Hahn D; Hodson EM; Ravani P; Pfister K; Quinn RR; Samuel SM
Cochrane Database Syst Rev; 2024 Jun; 6(6):CD015060. PubMed ID: 38864363
[TBL] [Abstract][Full Text] [Related]
33. Non-corticosteroid treatment for nephrotic syndrome in children.
Durkan A; Hodson E; Willis N; Craig J
Cochrane Database Syst Rev; 2001; (4):CD002290. PubMed ID: 11687155
[TBL] [Abstract][Full Text] [Related]
34. Non-corticosteroid treatment for nephrotic syndrome in children.
Durkan A; Hodson EM; Willis NS; Craig JC
Cochrane Database Syst Rev; 2005 Apr; (2):CD002290. PubMed ID: 15846634
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis.
Gong L; Xu M; Xu W; Tang W; Lu J; Jiang W; Xie F; Ding L; Qian X
Medicine (Baltimore); 2021 Jul; 100(28):e26628. PubMed ID: 34260552
[TBL] [Abstract][Full Text] [Related]
36. Overview of current and alternative therapies for idiopathic membranous nephropathy.
Tran TH; J Hughes G; Greenfeld C; Pham JT
Pharmacotherapy; 2015 Apr; 35(4):396-411. PubMed ID: 25884528
[TBL] [Abstract][Full Text] [Related]
37. Chinese herbal medicine Huangqi type formulations for nephrotic syndrome.
Feng M; Yuan W; Zhang R; Fu P; Wu T
Cochrane Database Syst Rev; 2013 Jun; (6):CD006335. PubMed ID: 23740567
[TBL] [Abstract][Full Text] [Related]
38. Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis.
Liu D; Yang Y; Kuang F; Qing S; Hu B; Yu X
Int Immunopharmacol; 2019 May; 70():354-361. PubMed ID: 30852290
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of idiopathic membranous nephropathy].
Passerini P
G Ital Nefrol; 2004; 21(6):531-9. PubMed ID: 15593020
[TBL] [Abstract][Full Text] [Related]
40. Multitarget therapy with a corticosteroid, cyclosporine and mycophenolate mofetil for idiopathic membranous nephropathy: a prospective randomized controlled trial.
Duan Y; Bai Y; Guo W; Wang L; Dai W; Guo W; Huang H; Liu W; Diao Z
Nephrol Dial Transplant; 2023 Dec; 39(1):95-102. PubMed ID: 37437905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
